Symbol
|
WEVLTQ | RMASRV | XRMLTQ | AAUYSQ | RMBBNV | ABBZSQ | RMBWDV | ABJASQ | BTJBKB | ZPRLTQ | OCGRCH | RMAZBV | RMAKXV | ONHRCH | OOJRCH | AARUTQ | AAXSTQ | Z24BPZ | RMAJ2V | OZURCH |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Name | Multi Reverse Convertible | Multi Vonti | Worst of Reverse Convertible | Reverse Convertible | Multi Vonti | Reverse Convertible | Multi Vonti | Multi Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Worst of Reverse Convertible | ZKB Reverse Convertible on worst of Last Look | Multi Vonti | Worst of Callable Reverse Convertible |
Underlying
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / UBS Group AG | Mitsubishi UFJ Financial Group Inc. / UBS Group AG | Swiss Life Hldg. N / Swiss RE AG / UBS Group AG / Zurich Insurance Group AG | Partners Group Hldg. AG / UBS Group AG | Roche GS / Swisscom / UBS | Nestlé / Novartis / Roche GS / UBS / Zurich | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | Givaudan / Novartis AG / Roche AG / Sandoz Group AG / Sonova Hldg. AG / UBS Group AG | Geberit AG / Partners Group Hldg. AG / Sika AG / Sonova Hldg. AG / UBS Group AG | Lonza Group N / Nestlé S.A. / Roche AG / UBS Group AG | Barry Callebaut AG / Nestlé S.A. / Roche AG / Swiss RE AG / UBS Group AG | JPMorgan Chase & Co. / Morgan Stanley / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | ABB / Lonza / UBS | Nestlé / Roche GS / UBS | Geberit AG / Nestlé S.A. / Novartis AG / UBS Group AG / Zurich Insurance Group AG |
Issuer
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Date of maturity
|
31.03.2028 | 10.02.2026 | 06.07.2026 | 18.08.2025 | 17.11.2025 | 01.12.2025 | 27.07.2026 | 08.04.2027 | 08.04.2027 | 23.04.2027 | 26.04.2027 | 28.05.2025 | 08.06.2026 | 08.07.2026 | 15.07.2026 | 13.08.2026 | 13.09.2027 | 16.09.2025 | 17.09.2025 | 07.07.2026 |
Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Strike price
|
49.63 | 51.70 | 1,034.00 | 269.36 | 735.00 | 166.845 | 16.24 | 43.685 | 43.685 | 42.50 | 15.8596 | 2,927.00 | 177.40 | 55.032 | 17.693 | 16.674 | 49.30 | 34.5525 | 19.72 | 61.344 |
Max. yield p.a. | 4.65% | 6.52% | - | -0.51% | 5.87% | 2.79% | 7.54% | 6.14% | 5.51% | 4.76% | 5.51% | 10.24% | 11.90% | 6.52% | 30.95% | 10.11% | 4.56% | 10.96% | 12.20% | 9.27% |
Bid | 100.59 | 100.80 | 206.58 | 101.30 | 99.80 | 100.95 | 98.00 | 98.18 | 98.04 | 99.56 | 97.34 | 99.20 | 95.50 | 98.28 | 76.68 | 99.44 | 99.75 | - | 99.30 | 97.29 |
Ask | 101.40 | 102.30 | 208.66 | 102.11 | 101.30 | 101.76 | 99.50 | 98.98 | 98.84 | 100.36 | 98.14 | 102.50 | 96.90 | 99.08 | 77.45 | 100.24 | 100.55 | - | 100.80 | 98.09 |